FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.

The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric pa ...

The VERONA trial evaluated the safety and efficacy of venetoclax with azacitidine in treatment-naïve adults with higher-risk MDS.

A cooperative model may at time better serve the relationship between patient and clinician. Healthcare professionals can be a competitive bunch. Many have wound a long and demanding road to achieve ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

Similar increases observed for higher-order births; increase in mean age at first birth seen in all racial and ethnic groups.

Heaviest burden born by regions with high sociodemographic index, apart from Japan, which had declining trends.

Pediatricians should provide their patients with their contraceptive of choice, if no medical contraindications exist.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

A second case of acute liver failure resulting in death has been reported in nonambulatory DMD patients treated with Elevidys.

HealthDay News — Mindfulness (MI) and transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex offer therapeutic benefit for reducing situational urgency urinary ...